Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 06-2003 | 12-2002 | 06-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,190 | -2,060 | -1,930 | -1,930 | -1,870 |
| Depreciation Amortization | 10 | 30 | 20 | 20 | 20 |
| Other Working Capital | 230 | -110 | -170 | -170 | 210 |
| Other Operating Activity | 1,090 | 140 | 770 | 770 | 160 |
| Operating Cash Flow | $-860 | $-2,000 | $-1,310 | $-1,310 | $-1,480 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -30 | -20 | -20 | -20 |
| Other Investing Activity | 632 | 1,530 | -4,060 | -4,060 | -70 |
| Investing Cash Flow | $630 | $1,500 | $-4,080 | $-4,080 | $-90 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 190 | 20 | 6,170 | 6,170 | 30 |
| Financing Cash Flow | $190 | $20 | $6,170 | $6,170 | $30 |
| Beginning Cash Position | 320 | 790 | 10 | 10 | 1,550 |
| End Cash Position | 280 | 320 | 790 | 790 | 10 |
| Net Cash Flow | $-30 | $-470 | $780 | $780 | $-1,540 |
| Free Cash Flow | |||||
| Operating Cash Flow | -860 | -2,000 | -1,310 | -1,310 | -1,480 |
| Free Cash Flow | -860 | -2,000 | -1,310 | -1,310 | -1,480 |